MedPath

Amphera BV

Amphera BV logo
🇳🇱Netherlands
Ownership
Holding
Established
2012-01-01
Employees
-
Market Cap
-
Website
http://www.amphera.nl

Clinical Trials

2

Active:1
Completed:1

Trial Phases

2 Phases

Phase 1:1
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (50.0%)
Phase 2
1 (50.0%)

DENdritic Cell Immunotherapy for Mesothelioma

Phase 2
Completed
Conditions
Mesothelioma
Interventions
First Posted Date
2018-08-01
Last Posted Date
2024-02-01
Lead Sponsor
Amphera BV
Target Recruit Count
176
Registration Number
NCT03610360
Locations
🇧🇪

University Hospital Antwerp, Antwerp, Belgium

🇫🇷

Centre Hospitalier Régional Universitaire de Lille, Lille, France

🇮🇹

Universitá Politecnica delle Marche - Ospedali Riuniti di Ancona, Ancona, Italy

and more 3 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.